Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases as D-amino acid oxidase inhibitors

Details for Australian Patent Application No. 2006298563 (hide)

Owner Merck Sharp & Dohme Limited Merck & Co., Inc.

Inventors Brandon, Nicholas; Brandish, Philip E.; Zheng, Wei; Sparey, Timothy; Campbell, Alister; Pike, Andrew

Agent Spruson & Ferguson

Pub. Number AU-A-2006298563

PCT Pub. Number WO2007/039773

Priority 0602783.3 13.02.06 GB; 0520316.1 06.10.05 GB

Filing date 5 October 2006

Wipo publication date 12 April 2007

International Classifications

A61K 31/33 (2006.01) - Heterocyclic compounds

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/039773 Priority application(s): WO2007/039773

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006298565-Oxycombustion method in which all of the carbon dioxide produced can be captured

2006298559-Pharmaceutical compositions stabilized in glassy particles